NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.

Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential.

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and immunotherapies.

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live beyond uncertainty.